How to Buy Outlook Therapeutics Stock
Outlook Therapeutics Inc
Outlook Therapeutics, Inc. , a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications.
Outlook Therapeutics stock last closed at $8.19, down 0.12% from the previous day, and has decreased 62.43% in one year. It has underperformed other stocks in the Biotechnology industry by 0.39 percentage points. Outlook Therapeutics stock is currently +104.55% from its 52-week low of $4.00, and -79.83% from its 52-week high of $40.60.
As of Apr 25, 2024, there are 13.01M OTLK shares outstanding. The market value of OTLK is $106.58M. In the last 24 hours, 150,455 OTLK shares were traded.
How to Buy Outlook Therapeutics Stock
Not sure how to invest in Outlook Therapeutics stock? Here's how.
- Decide where to buy Outlook Therapeutics stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Outlook Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Pick your method of payment and add your information.
- Research Outlook Therapeutics stock: The Outlook Therapeutics ticker symbol is OTLK. Is Outlook Therapeutics stock a good investment? Should you buy shares of OTLK? How do OTLK's underlying business fundamentals look? Do top analysts think Outlook Therapeutics is a good buy? Why has OTLK's stock price moved recently? (Hint: Our stock market analysis website can help you decide if OTLK is a good stock to buy).
- Place your OTLK buy order: Decide if you will purchase OTLK shares at the current market price or use a limit order to buy OTLK stock at a specific price.
- Get key alerts regarding your OTLK position: Create a watchlist to get live updates on your new investment in Outlook Therapeutics stock.
Step 1: Decide where to buy Outlook Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy OTLK shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal info so you can invest in OTLK stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have created your account on apps for stocks, you can securely and quickly fund your account:
Watch the tutorial below for more details transferring funds into your new brokerage account.
Step 4: Research Outlook Therapeutics stock
Once you have chosen the best place to buy Outlook Therapeutics stock, it's important to analyze their stock before you buy, so you actually wrap your head around the risk as well as the upside.
Overview of key OTLK info
Outlook Therapeutics Fundamentals
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on OTLK's stock page.
Is OTLK stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge OTLK's intrinsic value.
You can do more valuation research on OTLK's stock here.
OTLK Financial Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the OTLK balance sheet.
Failed Financial Due Diligence Checks:
- OTLK has $10.36M in cash and short term investments. This is not sufficient to cover its annual cash burn of $47.10M.
- Total OTLK debt is still negative.
- There are more short-term liabilities than short-term assets on the OTLK balance sheet.
- OTLK has cash burn of 47104321. It does not have sufficient cash and short-term investments to cover this.
- OTLK debt to equity ratio of -1.89 is negative.
Is OTLK stock a Buy, Hold, or Sell, according to analysts?
Out of 7 sell side analysts who monitor OTLK, the consensus analyst rating on OTLK is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent OTLK Analyst Upgrades/Downgrades
Zegbeh Jallah, a top 3% analyst from Capital One Financial upgrades OTLK to a buy rating and announces their OTLK price target of $100.00, on Dec 27, 2023.
Douglas Tsao, a top 18% analyst from HC Wainwright & Co. maintains OTLK with a buy rating and raises their OTLK price target from $20.00 to $40.00, on Nov 3, 2023.
You can dive deeper into what analysts are saying on the Outlook Therapeutics stock forecast page.
OTLK Technicals
Is OTLK Making Money?
Last year, OTLK revenue was $0.00. In the past five year, OTLK's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 28.62%.
Dive into OTLK's earnings and revenue performance here.
What are OTLK executives and large shareholders up to?
Over the past 12 months, executives and large shareholders at OTLK have bought more shares than they have sold.
Yezan Munther Haddadin, Director of OTLK, was the latest OTLK insider to buy. They bought $22,233.42 worth of OTLK shares on Mar 28, 2024.
Learn more about who owns OTLK stock here.
Can I get consistent income from OTLK stock?
No, Outlook Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about OTLK?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your OTLK buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price, place a limit order.
Click the Open button and your broker will place your order.
If you require additional info about investing in stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your OTLK position
Now that you own some OTLK stock, you'll want to keep up with your shares.
Start a watchlist to get the latest updates about your OTLK stock.
OTLK Feed
How to Buy Stock in Outlook Therapeutics
To reiterate, here are the 6 steps to buy stock in Outlook Therapeutics:
- Decide where to buy Outlook Therapeutics stock
- Open your brokerage account
- Deposit money your investment account
- Research Outlook Therapeutics stock
- Place your OTLK buy order
- Get key alerts regarding your OTLK position
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your investment in Outlook Therapeutics, create your watchlist below.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.